


To provide the potential for reliable growth by tracking the performance of those companies in the FTSE World Index which are engaged in Health, Pharmaceuticals and Biotechnology.
| Latest Price | 89.88p | IMA Sector | Specialist |
|---|---|---|---|
| Currency | British Pound | Launch Date | 01/11/2000 |
| Fund Size | n/a | Fund Manager | Ali Toutounchi |
| ISIN | GB00B0CNH270 | Dividend | 0.59p |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 89.88p |
| Currency | GBP |
| Change | 0.97p |
| % | 1.09% |
| YTD change | -7.06p |
| YTD % | -7.28% |
| Fund Inception | 01/11/2000 |
|---|---|
| Fund Manager | Ali Toutounchi |
| TER | 0.31 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.30% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | -0.09 |
You are here: research